Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124832055 | 12483205 | 5 | F | 20160822 | 20160621 | 20160828 | EXP | GB-AMGEN-GBRSP2016076020 | AMGEN | 63.00 | YR | A | M | Y | 0.00000 | 20160828 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124832055 | 12483205 | 1 | PS | XGEVA | DENOSUMAB | 1 | Subcutaneous | 120 MG, UNK | U | 125320 | 120 | MG | SOLUTION FOR INJECTION | ||||||
| 124832055 | 12483205 | 2 | SS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK | U | 0 | UNKNOWN FORMULATION | ||||||||
| 124832055 | 12483205 | 3 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 345 MG, UNK | 0 | 345 | MG | ||||||||
| 124832055 | 12483205 | 4 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | UNK | 0 | ||||||||||
| 124832055 | 12483205 | 5 | C | PREGABALIN. | PREGABALIN | 1 | UNK | 0 | |||||||||||
| 124832055 | 12483205 | 6 | C | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | UNK | 0 | |||||||||||
| 124832055 | 12483205 | 7 | C | CHLORPHENAMINE | CHLORPHENIRAMINE MALEATE | 1 | UNK | 0 | |||||||||||
| 124832055 | 12483205 | 8 | C | FORCEVAL /08120001/ | MINERALSVITAMINS | 1 | UNK | 0 | |||||||||||
| 124832055 | 12483205 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 124832055 | 12483205 | 10 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | UNK | 0 | |||||||||||
| 124832055 | 12483205 | 11 | C | OXYCODONE | OXYCODONE | 1 | UNK | 0 | |||||||||||
| 124832055 | 12483205 | 12 | C | THIAMINE. | THIAMINE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124832055 | 12483205 | 1 | Product used for unknown indication |
| 124832055 | 12483205 | 2 | Product used for unknown indication |
| 124832055 | 12483205 | 3 | Product used for unknown indication |
| 124832055 | 12483205 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124832055 | 12483205 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124832055 | 12483205 | Alopecia | |
| 124832055 | 12483205 | Arthralgia | |
| 124832055 | 12483205 | Chronic obstructive pulmonary disease | |
| 124832055 | 12483205 | Dyspnoea exertional | |
| 124832055 | 12483205 | Failure to anastomose | |
| 124832055 | 12483205 | Insomnia | |
| 124832055 | 12483205 | Neuropathy peripheral | |
| 124832055 | 12483205 | Skin ulcer | |
| 124832055 | 12483205 | Spinal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |